Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in combinatorial chemistry & high throughput screening . Volume 1 / / editor, Rathnam Chaguturu, Center for Advanced Drug Research, SRI International, Harrisonburg, VA 22802, USA
| Advances in combinatorial chemistry & high throughput screening . Volume 1 / / editor, Rathnam Chaguturu, Center for Advanced Drug Research, SRI International, Harrisonburg, VA 22802, USA |
| Pubbl/distr/stampa | Sharjah, U.A.E. : , : Bentham Science Publishers, , [2013] |
| Descrizione fisica | 1 online resource (274 p.) |
| Disciplina | 547.2 |
| Altri autori (Persone) | ChaguturuRathnam |
| Collana | Advances in combinatorial chemistry & high throughput screening |
| Soggetto topico | Combinatorial chemistry |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-60805-745-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover; Title; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Index |
| Altri titoli varianti | Advances in combinatorial chemistry and high throughput screening |
| Record Nr. | UNINA-9910462569003321 |
| Sharjah, U.A.E. : , : Bentham Science Publishers, , [2013] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in combinatorial chemistry & high throughput screening . Volume 1 / / editor, Rathnam Chaguturu, Center for Advanced Drug Research, SRI International, Harrisonburg, VA 22802, USA
| Advances in combinatorial chemistry & high throughput screening . Volume 1 / / editor, Rathnam Chaguturu, Center for Advanced Drug Research, SRI International, Harrisonburg, VA 22802, USA |
| Pubbl/distr/stampa | Sharjah, U.A.E. : , : Bentham Science Publishers, , [2013] |
| Descrizione fisica | 1 online resource (274 p.) |
| Disciplina | 547.2 |
| Altri autori (Persone) | ChaguturuRathnam |
| Collana | Advances in combinatorial chemistry & high throughput screening |
| Soggetto topico | Combinatorial chemistry |
| ISBN | 1-60805-745-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover; Title; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Index |
| Altri titoli varianti | Advances in combinatorial chemistry and high throughput screening |
| Record Nr. | UNINA-9910787515603321 |
| Sharjah, U.A.E. : , : Bentham Science Publishers, , [2013] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in combinatorial chemistry & high throughput screening . Volume 1 / / editor, Rathnam Chaguturu, Center for Advanced Drug Research, SRI International, Harrisonburg, VA 22802, USA
| Advances in combinatorial chemistry & high throughput screening . Volume 1 / / editor, Rathnam Chaguturu, Center for Advanced Drug Research, SRI International, Harrisonburg, VA 22802, USA |
| Pubbl/distr/stampa | Sharjah, U.A.E. : , : Bentham Science Publishers, , [2013] |
| Descrizione fisica | 1 online resource (274 p.) |
| Disciplina | 547.2 |
| Altri autori (Persone) | ChaguturuRathnam |
| Collana | Advances in combinatorial chemistry & high throughput screening |
| Soggetto topico | Combinatorial chemistry |
| ISBN | 1-60805-745-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Cover; Title; EUL; Contents; Foreword; Preface; List of Contributors; Chapter 01; Chapter 02; Chapter 03; Chapter 04; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Index |
| Altri titoli varianti | Advances in combinatorial chemistry and high throughput screening |
| Record Nr. | UNINA-9910819359603321 |
| Sharjah, U.A.E. : , : Bentham Science Publishers, , [2013] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Collaborative innovation in drug discovery : strategies for public and private partnerships / / edited by Dr. Rathnam Chaguturu ; Nobel Laureate Ferid Murad, foreword ; contributors Khusru Asadullah [and sixty four others]
| Collaborative innovation in drug discovery : strategies for public and private partnerships / / edited by Dr. Rathnam Chaguturu ; Nobel Laureate Ferid Murad, foreword ; contributors Khusru Asadullah [and sixty four others] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley, , 2014 |
| Descrizione fisica | 1 online resource (760 p.) |
| Disciplina | 615.1/9 |
| Collana | Wiley Series on Technologies for the Pharmaceutical Industry |
| Soggetto topico |
Drug Discovery
Public-Private Sector Partnerships Drug development Public-private sector cooperation |
| ISBN |
1-118-77816-2
1-118-77815-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title page; Copyright page; Dedication; Collaborative Drug Discovery Ethos; Contents; Foreword; Preface; About the Book; About the Editor; Contributors; Part I: Perspectives on Collaborative Innovation; 1: Productive Relationships in Research and Development between Government, Industry, and Universities; Universities, Government, and Industry: Historical Beginnings in Prussia; Refinement and Broad Adoption: the United States; Land Grants; Investments in Research; Intellectual Property; Impact on U.S. Economy; General Principles for Success; Governments; Universities; Industry
2: Divided We FallChallenges; Collaboration Models; Examples of Successful Biomedical Collaborations; Biomarkers Consortium; Predictive Safety Testing Consortium; SNP and SAEC Consortia; Principles of Collaboration; Governance, Administration, and Autonomy; Human Factors; Conclusion; References; 3: Innovation: Open Source and Nonprofit Models in Drug Discovery; Why Do People Innovate?; How Do We Encourage Innovation?; Why Is Innovation Important?; Warnings Regarding Innovation in Drug Discovery; Open Source Models; Nonprofit Models; Recommendations; References 4: The Changing Face of Innovation in Drug DiscoveryIntroduction; Core Objectives of the Drug Discovery Process; Major Innovations in Technology Have Advanced Drug Discovery; Target Identification and Target Validation; Hit Identification: The First Stage in Drug Hunting; Lead Optimization: A Field to Which Companies Must Commit Major Amounts of Human and Financial Resources; Preclinical Assessment: Select the First-in-Class and/or Best-in-Class Drug Candidate for Clinical Development; An Important Trend: Academic and Pharmaceutical Organizations Are Collaborating in Support of Drug Discovery Future Perspectives: Where Is Innovation Leading?References; 5: Current Trends in Collaborative Drug Discovery and Strategies to De-Risk Precompetitive Initiatives; Pharmaceutical Industry's Perspective; Academia's Perspective; Open (Collaborative) Innovation: A New Business Model; Drug Discovery through Collaborations; Drug Discovery through Consortia; Drug Discovery through Repurposing Strategies; Probe Discovery in Public Domain; Effective Management of Academia-Pharma Collaborations; Concluding Remarks; References 6: A Perspective on the Evolution of Collaborative Drug Discovery and Future ChallengesEvolution of Collaborative Drug Discovery; Challenges for Collaborative Drug Discovery; Conclusion; References; Part II: Governmental Initiatives Accelerate Precompetitive Collaboration; 7: The Value of University-Industry Partnerships; Guiding Principles for University-Industry Collaborations; The Johnson Continuum; Role of Cocreation: Companies, Government, and Universities; Maryland Industrial Partnerships (MIPS) Program; Funding for Collaborations with Academia New Initiatives to Transform University-Industry Collaborations |
| Record Nr. | UNINA-9910139118703321 |
| Hoboken, New Jersey : , : Wiley, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Collaborative innovation in drug discovery : strategies for public and private partnerships / / edited by Dr. Rathnam Chaguturu ; Nobel Laureate Ferid Murad, foreword ; contributors Khusru Asadullah [and sixty four others]
| Collaborative innovation in drug discovery : strategies for public and private partnerships / / edited by Dr. Rathnam Chaguturu ; Nobel Laureate Ferid Murad, foreword ; contributors Khusru Asadullah [and sixty four others] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley, , 2014 |
| Descrizione fisica | 1 online resource (760 p.) |
| Disciplina | 615.1/9 |
| Collana | Wiley Series on Technologies for the Pharmaceutical Industry |
| Soggetto topico |
Drug Discovery
Public-Private Sector Partnerships Drug development Public-private sector cooperation |
| ISBN |
1-118-77816-2
1-118-77815-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title page; Copyright page; Dedication; Collaborative Drug Discovery Ethos; Contents; Foreword; Preface; About the Book; About the Editor; Contributors; Part I: Perspectives on Collaborative Innovation; 1: Productive Relationships in Research and Development between Government, Industry, and Universities; Universities, Government, and Industry: Historical Beginnings in Prussia; Refinement and Broad Adoption: the United States; Land Grants; Investments in Research; Intellectual Property; Impact on U.S. Economy; General Principles for Success; Governments; Universities; Industry
2: Divided We FallChallenges; Collaboration Models; Examples of Successful Biomedical Collaborations; Biomarkers Consortium; Predictive Safety Testing Consortium; SNP and SAEC Consortia; Principles of Collaboration; Governance, Administration, and Autonomy; Human Factors; Conclusion; References; 3: Innovation: Open Source and Nonprofit Models in Drug Discovery; Why Do People Innovate?; How Do We Encourage Innovation?; Why Is Innovation Important?; Warnings Regarding Innovation in Drug Discovery; Open Source Models; Nonprofit Models; Recommendations; References 4: The Changing Face of Innovation in Drug DiscoveryIntroduction; Core Objectives of the Drug Discovery Process; Major Innovations in Technology Have Advanced Drug Discovery; Target Identification and Target Validation; Hit Identification: The First Stage in Drug Hunting; Lead Optimization: A Field to Which Companies Must Commit Major Amounts of Human and Financial Resources; Preclinical Assessment: Select the First-in-Class and/or Best-in-Class Drug Candidate for Clinical Development; An Important Trend: Academic and Pharmaceutical Organizations Are Collaborating in Support of Drug Discovery Future Perspectives: Where Is Innovation Leading?References; 5: Current Trends in Collaborative Drug Discovery and Strategies to De-Risk Precompetitive Initiatives; Pharmaceutical Industry's Perspective; Academia's Perspective; Open (Collaborative) Innovation: A New Business Model; Drug Discovery through Collaborations; Drug Discovery through Consortia; Drug Discovery through Repurposing Strategies; Probe Discovery in Public Domain; Effective Management of Academia-Pharma Collaborations; Concluding Remarks; References 6: A Perspective on the Evolution of Collaborative Drug Discovery and Future ChallengesEvolution of Collaborative Drug Discovery; Challenges for Collaborative Drug Discovery; Conclusion; References; Part II: Governmental Initiatives Accelerate Precompetitive Collaboration; 7: The Value of University-Industry Partnerships; Guiding Principles for University-Industry Collaborations; The Johnson Continuum; Role of Cocreation: Companies, Government, and Universities; Maryland Industrial Partnerships (MIPS) Program; Funding for Collaborations with Academia New Initiatives to Transform University-Industry Collaborations |
| Record Nr. | UNINA-9910815052503321 |
| Hoboken, New Jersey : , : Wiley, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||